Alessandro Rossetta

Established in 2019 as an Italian startup, FLIM LABS has swiftly risen as a pioneer in the dynamic realm of fluorescence lifetime analysis technology. Founded by Alessandro Rossetta, Ph.D., in Bioengineering and now led by him as CEO, the company traces its origins back to its inception with the support of ‘PRE-SEED’ funds from Regione Lazio. Since then, FLIM LABS has seen continuous growth, earning accolades from esteemed institutions like Regione Emilia Romagna and the Photon Hub Europe technology accelerator programs. Since January 2024, FLIM LABS has remained at the forefront of fluorescence lifetime analysis technology, leading the LaserBlood EIC Pathfinder consortium in developing a groundbreaking method for early pancreatic cancer diagnosis via liquid biopsy.

At the core of FLIM LABS’ mission is a dedication to providing reliable, portable, user-friendly, and affordable fluorescence lifetime analysis tools. These tools are engineered to seamlessly acquire and process fluorescence lifetime data in real time, embodying a commitment to both technological innovation and practicality. FLIM LABS’ instruments are designed to be plug-and-play, remarkably user-friendly, and easily upgradable.

Devoted to advancing fluorescence lifetime technology, FLIM LABS distinguishes itself as one of the few companies focused on developing specialized technical components tailored for fluorescence lifetime experiments. By championing accessibility and simplicity, FLIM LABS is breaking down barriers, making fluorescence lifetime-based technology accessible to a broader community of scientists and researchers, poised to explore new horizons.